Asset Allocation
| Position | Category/Sector | Target Weight |
|---|---|---|
RIGL Rigel Pharmaceuticals, Inc. | Healthcare | 10% |
BLND Blend Labs, Inc. | Technology | 10% |
TVTX Travere Therapeutics, Inc. | Healthcare | 10% |
ATRA Atara Biotherapeutics, Inc. | Healthcare | 10% |
OKTA Okta, Inc. | Technology | 10% |
TSLA Tesla, Inc. | Consumer Cyclical | 10% |
CRM Salesforce, Inc. | Technology | 10% |
AMZN Amazon.com, Inc | Consumer Cyclical | 10% |
MSFT Microsoft Corporation | Technology | 10% |
NRG NRG Energy, Inc. | Utilities | 10% |
Find the right asset allocation for Grok 2: Growth ETFs
Add portfolio to the optimizer to find optimal allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio OptimizerPerformance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Grok 2: Growth ETFs, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is never rebalanced.
Loading charts...
Returns By Period
| Position | 1D | 1M | YTD | 6M | 1Y | 3Y* | 5Y* | 10Y* |
|---|---|---|---|---|---|---|---|---|
Benchmark S&P 500 Index | 0.30% | 0.09% | 8.18% | 8.17% | 23.42% | 19.88% | 11.91% | 13.45% |
Portfolio Grok 2: Growth ETFs | 0.70% | 0.30% | -8.00% | -6.79% | 15.15% | 26.38% | — | — |
| Portfolio components: | ||||||||
AMZN Amazon.com, Inc | -0.33% | -10.07% | 6.24% | 8.08% | 14.82% | 25.71% | 8.37% | 21.19% |
ATRA Atara Biotherapeutics, Inc. | -3.43% | 14.87% | -47.04% | -36.47% | 3.79% | -42.16% | -51.49% | -32.50% |
BLND Blend Labs, Inc. | 5.56% | 23.91% | -43.75% | -46.89% | -54.28% | 20.39% | — | — |
CRM Salesforce, Inc. | -1.68% | 0.40% | -30.92% | -29.37% | -33.00% | -4.89% | -4.74% | 8.51% |
MSFT Microsoft Corporation | -1.18% | -0.60% | -14.48% | -15.77% | -11.77% | 8.85% | 11.09% | 24.64% |
NRG NRG Energy, Inc. | -1.15% | -7.53% | -19.30% | -21.70% | -17.17% | 58.56% | 31.87% | 26.54% |
OKTA Okta, Inc. | -1.58% | 39.27% | 35.13% | 33.86% | 11.20% | 17.84% | -11.66% | — |
RIGL Rigel Pharmaceuticals, Inc. | 0.50% | 15.51% | -29.77% | -30.69% | 39.97% | 23.16% | -5.96% | 2.33% |
TSLA Tesla, Inc. | 4.59% | -4.53% | -9.07% | -6.97% | 38.56% | 18.72% | 15.43% | 39.56% |
TVTX Travere Therapeutics, Inc. | 2.77% | 10.52% | 23.21% | 37.30% | 207.31% | 41.35% | 25.91% | 10.47% |
Monthly Returns
Based on dividend-adjusted daily data since Jul 16, 2021, Grok 2: Growth ETFs's average daily return is +0.05%, while the average monthly return is +0.82%. At this rate, an investment would double in approximately 7.1 years.
Historically, 50% of months were positive and 50% were negative. The best month was Nov 2024 with a return of +17.4%, while the worst month was Apr 2022 at -15.1%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 8 months.
On a daily basis, Grok 2: Growth ETFs closed higher 53% of trading days. The best single day was May 12, 2025 with a return of +11.4%, while the worst single day was May 2, 2023 at -8.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.52% | 0.57% | -9.92% | 13.21% | 3.95% | -4.62% | -8.00% | ||||||
| 2025 | 7.65% | -6.48% | -9.89% | 8.47% | 14.09% | 1.55% | 3.27% | -0.25% | 8.64% | 10.54% | -0.19% | -0.33% | 40.29% |
| 2024 | -2.04% | 7.06% | 3.31% | -5.61% | 3.60% | 3.99% | 1.63% | 2.02% | 11.24% | 0.99% | 17.38% | -3.33% | 45.62% |
| 2023 | 15.29% | -1.27% | 4.82% | -4.92% | 4.04% | 1.63% | 5.21% | -5.19% | -8.57% | -5.29% | 13.17% | 9.41% | 28.30% |
| 2022 | -8.16% | -4.83% | -1.19% | -15.05% | -6.89% | -4.85% | 4.39% | 1.59% | -10.02% | -3.40% | -5.44% | -9.43% | -48.69% |
| 2021 | -1.03% | 10.74% | -0.50% | 9.25% | -3.15% | -2.25% | 12.77% |
Benchmark Metrics
Grok 2: Growth ETFs has an annualized alpha of -5.74%, beta of 1.40, and R2 of 0.63 versus S&P 500 Index. Calculated based on daily prices since July 16, 2021.
- This portfolio participated in 118.40% of S&P 500 Index downside but only 101.99% of its upside - more exposed to losses than it benefited from rallies.
- This portfolio had an annualized alpha of -5.74% versus S&P 500 Index - delivering less than market exposure alone would predict.
- Alpha
- -5.74%
- Beta
- 1.40
- R²
- 0.63
- Upside Capture
- 101.99%
- Downside Capture
- 118.40%
Expense Ratio
Grok 2: Growth ETFs has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.
Return for Risk
Risk / Return Rank
Grok 2: Growth ETFs ranks 9 for risk / return — in the bottom 9% of Portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below presents risk-adjusted performance metrics for Grok 2: Growth ETFs and compares them with S&P 500 Index.
| Portfolio | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | 0.60 | 1.94 | -1.34 |
| Sortino ratioReturn per unit of downside risk | 1.02 | 2.63 | -1.61 |
| Omega ratioGain probability vs. loss probability | 1.12 | 1.35 | -0.23 |
| Calmar ratioReturn relative to maximum drawdown | 0.65 | 2.59 | -1.94 |
| Martin ratioReturn relative to average drawdown | 1.73 | 11.84 | -10.12 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.
| Position | Risk / Return Rank | Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio |
|---|---|---|---|---|---|---|
AMZN Amazon.com, Inc | 56 | 0.49 | 0.89 | 1.11 | 0.68 | 1.64 |
ATRA Atara Biotherapeutics, Inc. | 51 | 0.03 | 1.21 | 1.19 | 0.05 | 0.09 |
BLND Blend Labs, Inc. | 12 | -0.76 | -0.97 | 0.88 | -0.80 | -1.33 |
CRM Salesforce, Inc. | 8 | -0.88 | -1.17 | 0.86 | -0.84 | -1.62 |
MSFT Microsoft Corporation | 24 | -0.47 | -0.49 | 0.94 | -0.35 | -0.73 |
NRG NRG Energy, Inc. | 22 | -0.39 | -0.27 | 0.97 | -0.53 | -1.31 |
OKTA Okta, Inc. | 50 | 0.21 | 0.77 | 1.10 | 0.30 | 0.71 |
RIGL Rigel Pharmaceuticals, Inc. | 61 | 0.58 | 1.40 | 1.17 | 0.80 | 1.41 |
TSLA Tesla, Inc. | 66 | 0.87 | 1.43 | 1.17 | 1.29 | 3.01 |
TVTX Travere Therapeutics, Inc. | 94 | 2.92 | 3.86 | 1.48 | 6.23 | 14.39 |
Loading charts...
Dividends
Dividend yield
Grok 2: Growth ETFs provided a 0.32% dividend yield over the last twelve months.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portfolio | 0.32% | 0.24% | 0.30% | 0.37% | 0.55% | 0.37% | 0.41% | 0.15% | 0.20% | 0.23% | 0.43% | 0.73% |
| Portfolio components: | ||||||||||||
AMZN Amazon.com, Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ATRA Atara Biotherapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BLND Blend Labs, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CRM Salesforce, Inc. | 0.92% | 0.63% | 0.48% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MSFT Microsoft Corporation | 0.86% | 0.70% | 0.73% | 0.74% | 1.06% | 0.68% | 0.94% | 1.20% | 1.69% | 1.86% | 2.37% | 2.33% |
NRG NRG Energy, Inc. | 1.43% | 1.11% | 1.81% | 2.92% | 4.40% | 3.02% | 3.20% | 0.30% | 0.30% | 0.42% | 1.92% | 4.93% |
OKTA Okta, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TSLA Tesla, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TVTX Travere Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Grok 2: Growth ETFs. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Grok 2: Growth ETFs was 56.58%, occurring on Dec 27, 2022. Recovery took 595 trading sessions.
The current Grok 2: Growth ETFs drawdown is 10.51%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Bear market2022 | -56.58%Dec 2022 | 1y 1mo | 2y 4mo | 3y 6moNov 2021 - May 2025 |
2026 bear market2026 | -23.51%Mar 2026 | 3mo 4d | — | 5mo 15dDec 2025 - now |
2025 selloff2025 | -6.61%Jun 2025 | 1mo 2d | 1mo 14d | 2mo 16dMay 2025 - Jul 2025 |
2025 pullback2025 | -6.30%Nov 2025 | 16d | 1mo 4d | 1mo 20dNov 2025 - Dec 2025 |
2025 pullback2025 | -5.05%Oct 2025 | 17d | 14d | 1mo 1dSep 2025 - Oct 2025 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Diversification
Diversification Metrics
Number of Effective Assets
The portfolio contains 10 assets, with an effective number of assets of 10.00, reflecting the diversification based on asset allocation. Your capital is spread almost evenly across your holdings, indicating a well-balanced allocation. Note that true diversification also depends on the correlations between assets — check the diversification ratio below.
Diversification Ratio
1Y | 3Y | All Time | |
|---|---|---|---|
Diversification Ratio | 2.09 | 1.89 | 1.79 |
The portfolio has a diversification ratio of 1.79, in line with the typical range across portfolios. There's room to improve by adding less correlated assets.
Grok 2: Growth ETFs correlation to the S&P 500 Index
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.66 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.76 |
Correlation (All Time) Calculated using the full available price history since Jul 16, 2021 | 0.77 |
Benchmark Correlations
Correlation vs. S&P 500 Index. MSFT has the highest benchmark correlation at 0.73, while RIGL has the lowest at 0.32.
Asset Correlations Table
| NRG | RIGL | ATRA | BLND | TVTX | TSLA | OKTA | CRM | MSFT | AMZN | |
|---|---|---|---|---|---|---|---|---|---|---|
| NRG | 1.00 | 0.18 | 0.14 | 0.15 | 0.21 | 0.23 | 0.20 | 0.24 | 0.28 | 0.29 |
| RIGL | 0.18 | 1.00 | 0.32 | 0.22 | 0.39 | 0.21 | 0.27 | 0.24 | 0.19 | 0.22 |
| ATRA | 0.14 | 0.32 | 1.00 | 0.22 | 0.34 | 0.27 | 0.26 | 0.26 | 0.24 | 0.26 |
| BLND | 0.15 | 0.22 | 0.22 | 1.00 | 0.24 | 0.30 | 0.40 | 0.34 | 0.28 | 0.30 |
| TVTX | 0.21 | 0.39 | 0.34 | 0.24 | 1.00 | 0.25 | 0.25 | 0.23 | 0.21 | 0.23 |
| TSLA | 0.23 | 0.21 | 0.27 | 0.30 | 0.25 | 1.00 | 0.37 | 0.37 | 0.42 | 0.46 |
| OKTA | 0.20 | 0.27 | 0.26 | 0.40 | 0.25 | 0.37 | 1.00 | 0.61 | 0.48 | 0.47 |
| CRM | 0.24 | 0.24 | 0.26 | 0.34 | 0.23 | 0.37 | 0.61 | 1.00 | 0.56 | 0.52 |
| MSFT | 0.28 | 0.19 | 0.24 | 0.28 | 0.21 | 0.42 | 0.48 | 0.56 | 1.00 | 0.64 |
| AMZN | 0.29 | 0.22 | 0.26 | 0.30 | 0.23 | 0.46 | 0.47 | 0.52 | 0.64 | 1.00 |
Find what Grok 2: Growth ETFs is missing
See which holdings overlap, where Grok 2: Growth ETFs is concentrated, and which low-correlation assets could fill the gaps.
Analyze Diversification